How Long Should You Take Glp-1 Drugs? Study Links Longer Use To Lower Heart Risk

New real-world grounds suggests that staying connected GLP-1 therapy whitethorn beryllium captious for sustaining cardiovascular protection, while moreover short interruptions could diminish semipermanent benefits successful group pinch type 2 diabetes.

Study: Glucagon-like peptide 1 receptor agonist discontinuation and risks of awesome adverse cardiovascular events successful adults pinch type 2 diabetes: target proceedings emulation. Image Credit: Love Employee / Shutterstock

In a caller study published successful nan journal BMJ Medicine, researchers conducted a target proceedings emulation to measure associations betwixt different scenarios of glucagon-like peptide-1 receptor agonist (GLP-1RA) curen and nan consequence of awesome adverse cardiovascular events (MACE).

GLP-1RA usage is associated pinch wellness benefits, including weight nonaccomplishment and reduced MACE risk. This pleiotropic efficacy floor plan has accrued GLP-1RA use, pinch 12% of adults successful nan United States (US) reporting ever usage of GLP-1RAs. However, GLP-1RAs are besides associated pinch important adverse events and out-of-pocket costs, which could lend to their discontinuation.

Studies person recovered GLP-1RA discontinuation rates of 36%–81% successful nan first twelvemonth of treatment. Notably, discontinuation is associated pinch weight regain and partial aliases complete reversal of improvements successful cardiometabolic consequence factors, including inflammatory markers, humor pressure, lipid profile, and humor glucose levels. However, small is known astir nan consequences of discontinuation connected MACE risk.

Target Trial Emulation Using Real World Data

In nan coming study, researchers emulated a target proceedings assessing associations betwixt different GLP-1RA curen scenarios and MACE risk. The study utilized physics wellness records from nan US Department of Veterans Affairs (VA). VA users pinch type 2 glucosuria (T2D) who utilized sulfonylureas aliases GLP-1RAs betwixt 2017 and 2023 were identified, pinch follow-up extending until nan result occurred, 3 years aft curen initiation, aliases 31 December 2024, whichever came first.

Participants were excluded if they utilized these narcotics successful nan twelvemonth earlier enrolment aliases had contraindications to them. Subjects were followed for 3 years aliases until nan result occurred (or administrative censoring astatine nan extremity of follow-up). After nan commencement of GLP-1RA treatment, participants were deemed to person discontinued nan supplier if they did not person a refill for ≥ 90 days aft their medicine ended.

Individuals who stopped utilizing GLP-1RAs were categorized into interruption and discontinuation groups; nan interruption group resumed GLP-1RA usage immoderate clip aft cessation, while nan discontinuation group ne'er resumed. The researchers defined 16 GLP-1RA curen scenarios for GLP-1RA users by semi-annually reassigning their curen status, conditional connected their existent usage status, thereby emulating move curen strategies complete time.

Primary comparisons were made betwixt each of these scenarios and sulfonylurea treatment. In secondary analyses wrong nan GLP-1RA group, continued usage was compared pinch nan different scenarios. The superior result was MACE, a composite of myocardial infarction, stroke, and all-cause mortality. Marginal structural models were utilized to measure nan relation betwixt GLP-1RAs and MACE risk, accounting for time-varying confounding utilizing inverse probability weighting, though residual confounding cannot beryllium afloat excluded.

GLP-1RA Use Patterns and Discontinuation Rates

The study included 201,136 incident sulfonylurea users and 132,551 incident GLP-1RA users, pinch a median follow-up of 3 years. Among GLP-1RA users, 26.36% discontinued curen during follow-up, while 22.68% knowledgeable interruptions.

Continuous GLP-1RA Use Reduces MACE Risk

Incident usage of GLP-1RAs was associated pinch a little consequence of MACE compared to incident usage of sulfonylureas. The incidence consequence ratio (IRR) was 0.82 for continuous GLP-1RA use, 0.88 for interrupted use, and 0.96 for discontinued use, comparative to sulfonylurea use.

Longer long of GLP-1RA usage was associated pinch greater consequence reduction. Individuals who utilized GLP-1RAs for 0.5, 1, and 1.5 years had IRRs adjacent to 1.0, pinch nary important alteration successful MACE consequence astatine 3 years, though these estimates varied crossed circumstantial curen strategies defined by anterior long and consequent vulnerability patterns.

By contrast, MACE consequence was importantly little among those who continued GLP-1RA usage for 2 and 2.5 years, and lowest among those who maintained curen for 3 years. Within nan GLP-1RA group, discontinuing curen for moreover 0.5 years was associated pinch a higher MACE consequence compared to continued use.

Interruptions and Discontinuation Increase Cardiovascular Risk

Moreover, longer discontinuation was progressively associated pinch elevated MACE risk, pinch IRRs of 1.14 for 1 twelvemonth of discontinuation and 1.22 for 2 years. Similarly, interrupted usage was associated pinch accrued MACE risk, pinch IRRs of 1.12 for 1 twelvemonth and 1.16 for 2 years of interruption, pinch effect sizes differing modestly depending connected anterior curen duration.

Implications for Treatment Persistence and Outcomes

Taken together, discontinuations and interruptions successful GLP-1RA usage were communal successful this cohort, peculiarly during nan first twelvemonth of treatment. Continuous GLP-1RA usage for 3 years was associated pinch nan top simplification successful MACE consequence compared pinch sulfonylureas, whereas interruptions and discontinuations were associated pinch a progressive attenuation of this protective effect, pinch consequence estimates successful immoderate scenarios approaching those of nan comparator group.

These findings item nan imaginable value of curen persistence successful maximizing nan cardioprotective benefits of GLP-1RAs. However, arsenic this was an observational target proceedings emulation conducted successful a predominantly antheral Veterans Affairs population, nan results support but do not found causality and whitethorn person constricted generalisability to broader populations, peculiarly women and non-veteran groups.